機能不全のCD8T細胞は,ヒトメラノーマ内の増殖性,動的に調節された区画を形成する
Hanjie Li1, Anne M van der Leun2, Ido Yofe1
1Department of Immunology, Weizmann Institute, Rehovot, Israel.
Cell
|January 1, 2019
まとめ
メラノーマの腫瘍に浸透するCD8T細胞は,機能不全状態にダイナミックに進行する. これらの機能不全した細胞は 増殖率が高く 腫瘍の反応性に関連しており 枯渇したT細胞の以前の定義に 異議を唱えています
科学分野:
- 免疫学
- 腫瘍学
- ゲノミクス
背景:
- 腫瘍の免疫細胞の構成は,免疫療法の反応に重大な影響を及ぼします.
- ヒトがんにおける腫瘍内免疫細胞の異質性と動態は十分に理解されていません.
研究 の 目的:
- メラノーマにおける保存された腫瘍内CD4およびCD8T細胞の行動の特徴を明らかにする.
- 腫瘍の微小環境内のCD8T細胞状態の進行と特徴を調査する.
主な方法:
- 25人のメラノーマ患者の免疫浸透体の単細胞RNAシーケンシング (scRNA-seq).
- T細胞受容体 (TCR) の共有データ解析
- T細胞の機能と増殖に関連する遺伝子発現シグネチャーの評価
主要な成果:
- CD8 T細胞状態の連続性を識別した. 移行エフェクタから機能不全のフェノタイプまで.
- 希少なCD8T細胞は完全な細胞毒性遺伝子セットを表現し,移行状態と機能不全状態から独立している.
- 機能不全のCD8T細胞は,腫瘍内の主要な増殖免疫細胞集団を表しています.
- 機能障害の強さは腫瘍の反応性と相関する.
結論:
- 以前は"枯渇した"と 呼ばれていたヒトの腫瘍に浸透する CD8 T細胞は 実際には動的で増殖し,クローン集団である.
- これらの発見は,腫瘍の微小環境内のT細胞の行動とその免疫療法への影響に関する新しい洞察を提供します.
関連する概念動画
Proliferative Phase
1.4K
The proliferative phase typically occurs after menstruation and lasts between 6 to 13 days in a standard 28-day cycle. This phase involves the reconstruction of the endometrium, guided by estrogen produced by the developing ovarian follicle.
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
1.4K
pH Regulation in Cells
7.6K
pH plays a critical role in maintaining normal cellular activities. It helps maintain the structure and function of various proteins, dictates the charge on cellular membranes, and is crucial for metabolic reactions inside the cell. Moreover, cells use the energy from the proton motive force to generate ATP.
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
Cytosolic pH
Under physiological conditions, the cytosolic pH is slightly more acidic than the extracellular pH. However, cells must prevent further acidification of their cytosol to...
7.6K
Compartment Models: Two-Compartment Model
7.1K
The two-compartment model divides the body into central and peripheral compartments to account for varying blood perfusion rates among organs and tissues, affecting drug distribution. The central compartment includes blood and highly perfused tissues with rapid drug distribution, while the peripheral compartment contains tissues with slower drug distribution. After a single IV bolus dose, the drug concentration is high in plasma and low in tissues. The drug distribution between compartments...
7.1K
Epigenetic Regulation
33.7K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.7K
Master Transcription Regulators
7.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Compartment Models: Single-Compartment Model
3.2K
The single-compartment model serves as a simplified representation of the human body. This model assumes that the body functions as a single, well-mixed open compartment. When a drug is administered intravenously, it enters the body and quickly distributes uniformly. The drug then undergoes biotransformation and elimination, ultimately leaving the body. The volume of this compartment is referred to as the apparent volume of distribution into which the drug can uniformly distribute. In this...
3.2K


